PERSONALISED ANTIPLATELET TREATMENT STRATEGY AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI (PASTOR STUDY)

Verify Now platelet function testing was performed the following morning. 46 patients were found to be clopidogrel non-responders according to platelet reactivity measurements (cut-off PRU>235) and were treated with novel ADP inhibitors (44 with prasugrel, 4 with ticgarelor).

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A241-A241
Main Authors: Mikkelsson, Jussi, Paana, Tuomas, Lepantalo, Aino, Karjalainen, Pasi
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Medical research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A241
container_issue 10
container_start_page A241
container_title Journal of the American College of Cardiology
container_volume 65
creator Mikkelsson, Jussi
Paana, Tuomas
Lepantalo, Aino
Karjalainen, Pasi
description Verify Now platelet function testing was performed the following morning. 46 patients were found to be clopidogrel non-responders according to platelet reactivity measurements (cut-off PRU>235) and were treated with novel ADP inhibitors (44 with prasugrel, 4 with ticgarelor).
doi_str_mv 10.1016/S0735-1097(15)60241-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1675964866</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109715602418</els_id><sourcerecordid>3666666911</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2328-4eb8e22ede20f49b3d4241553257584c52c3e6954b1691da7685f8e7e5b7e9fa3</originalsourceid><addsrcrecordid>eNqFkFFr2zAQx8XoYGm3jzAw7KV98CbJPll-2TCJmhmc2NgKI0_Ckc_MbZakVlvot5-SjBX2sqfj7v73u7s_IR8Z_cwoE18amkQQMpom1wxuBOUxC-UbMmEAMowgTS7I5K_kHbl07o5SKiRLJ-RnpeqmXGZF3qhZkC11XhWZVoXSga5VphdqqYNG1742X_v-LChXelouVBPclkVR_siX86Cq80VWr4Nqmvtq7fVqkQfXVdboU7aarW_ek7d9u3X44U-8Iqtbpaffw6Kc59OsCC2PuAxj3EjkHDvktI_TTdTF_h2AiEMCMrbAbYQihXjDRMq6NhESeokJwibBtG-jK_LpzD2M-4cndI_mbv807vxKw0QCqYilEF4FZ5Ud986N2JvDOPxqxxfDqDmaak6mmqNjhoE5mWqkn_t2nkP_wvOAo3F2wJ3FbhjRPppuP_yX8PUfgt0Ou8G223t8Qfd6rHHc0DPkyGBwIsjoNzg9iXs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1675964866</pqid></control><display><type>article</type><title>PERSONALISED ANTIPLATELET TREATMENT STRATEGY AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI (PASTOR STUDY)</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Mikkelsson, Jussi ; Paana, Tuomas ; Lepantalo, Aino ; Karjalainen, Pasi</creator><creatorcontrib>Mikkelsson, Jussi ; Paana, Tuomas ; Lepantalo, Aino ; Karjalainen, Pasi</creatorcontrib><description>Verify Now platelet function testing was performed the following morning. 46 patients were found to be clopidogrel non-responders according to platelet reactivity measurements (cut-off PRU&gt;235) and were treated with novel ADP inhibitors (44 with prasugrel, 4 with ticgarelor).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(15)60241-8</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Drug therapy ; Internal Medicine ; Medical research</subject><ispartof>Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A241-A241</ispartof><rights>American College of Cardiology Foundation</rights><rights>2015 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 17, 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Mikkelsson, Jussi</creatorcontrib><creatorcontrib>Paana, Tuomas</creatorcontrib><creatorcontrib>Lepantalo, Aino</creatorcontrib><creatorcontrib>Karjalainen, Pasi</creatorcontrib><title>PERSONALISED ANTIPLATELET TREATMENT STRATEGY AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI (PASTOR STUDY)</title><title>Journal of the American College of Cardiology</title><description>Verify Now platelet function testing was performed the following morning. 46 patients were found to be clopidogrel non-responders according to platelet reactivity measurements (cut-off PRU&gt;235) and were treated with novel ADP inhibitors (44 with prasugrel, 4 with ticgarelor).</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Drug therapy</subject><subject>Internal Medicine</subject><subject>Medical research</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkFFr2zAQx8XoYGm3jzAw7KV98CbJPll-2TCJmhmc2NgKI0_Ckc_MbZakVlvot5-SjBX2sqfj7v73u7s_IR8Z_cwoE18amkQQMpom1wxuBOUxC-UbMmEAMowgTS7I5K_kHbl07o5SKiRLJ-RnpeqmXGZF3qhZkC11XhWZVoXSga5VphdqqYNG1742X_v-LChXelouVBPclkVR_siX86Cq80VWr4Nqmvtq7fVqkQfXVdboU7aarW_ek7d9u3X44U-8Iqtbpaffw6Kc59OsCC2PuAxj3EjkHDvktI_TTdTF_h2AiEMCMrbAbYQihXjDRMq6NhESeokJwibBtG-jK_LpzD2M-4cndI_mbv807vxKw0QCqYilEF4FZ5Ud986N2JvDOPxqxxfDqDmaak6mmqNjhoE5mWqkn_t2nkP_wvOAo3F2wJ3FbhjRPppuP_yX8PUfgt0Ou8G223t8Qfd6rHHc0DPkyGBwIsjoNzg9iXs</recordid><startdate>20150317</startdate><enddate>20150317</enddate><creator>Mikkelsson, Jussi</creator><creator>Paana, Tuomas</creator><creator>Lepantalo, Aino</creator><creator>Karjalainen, Pasi</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150317</creationdate><title>PERSONALISED ANTIPLATELET TREATMENT STRATEGY AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI (PASTOR STUDY)</title><author>Mikkelsson, Jussi ; Paana, Tuomas ; Lepantalo, Aino ; Karjalainen, Pasi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2328-4eb8e22ede20f49b3d4241553257584c52c3e6954b1691da7685f8e7e5b7e9fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Drug therapy</topic><topic>Internal Medicine</topic><topic>Medical research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikkelsson, Jussi</creatorcontrib><creatorcontrib>Paana, Tuomas</creatorcontrib><creatorcontrib>Lepantalo, Aino</creatorcontrib><creatorcontrib>Karjalainen, Pasi</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikkelsson, Jussi</au><au>Paana, Tuomas</au><au>Lepantalo, Aino</au><au>Karjalainen, Pasi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PERSONALISED ANTIPLATELET TREATMENT STRATEGY AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI (PASTOR STUDY)</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2015-03-17</date><risdate>2015</risdate><volume>65</volume><issue>10</issue><spage>A241</spage><epage>A241</epage><pages>A241-A241</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Verify Now platelet function testing was performed the following morning. 46 patients were found to be clopidogrel non-responders according to platelet reactivity measurements (cut-off PRU&gt;235) and were treated with novel ADP inhibitors (44 with prasugrel, 4 with ticgarelor).</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(15)60241-8</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A241-A241
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_1675964866
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Medical research
title PERSONALISED ANTIPLATELET TREATMENT STRATEGY AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI (PASTOR STUDY)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T11%3A36%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PERSONALISED%20ANTIPLATELET%20TREATMENT%20STRATEGY%20AND%20OUTCOMES%20FOLLOWING%20PRIMARY%20PCI%20FOR%20STEMI%20(PASTOR%20STUDY)&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Mikkelsson,%20Jussi&rft.date=2015-03-17&rft.volume=65&rft.issue=10&rft.spage=A241&rft.epage=A241&rft.pages=A241-A241&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(15)60241-8&rft_dat=%3Cproquest_cross%3E3666666911%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2328-4eb8e22ede20f49b3d4241553257584c52c3e6954b1691da7685f8e7e5b7e9fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1675964866&rft_id=info:pmid/&rfr_iscdi=true